Woodline Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,005
| Closed | -$376K | – | 972 |
|
|
2024
Q4 | $376K | Sell |
19,005
-15,024
| -44% | -$297K | ﹤0.01% | 864 |
|
|
2024
Q3 | $850K | Buy |
+34,029
| New | +$850K | 0.01% | 513 |
|
|
2023
Q3 | – | Sell |
-290,001
| Closed | -$4.08M | – | 677 |
|
|
2023
Q2 | $4.08M | Buy |
+290,001
| New | +$4.08M | 0.05% | 324 |
|
|
2022
Q3 | – | Sell |
-332,893
| Closed | -$3.23M | – | 787 |
|
|
2022
Q2 | $3.23M | Buy |
+332,893
| New | +$3.23M | 0.05% | 322 |
|
|
2021
Q4 | – | Sell |
-234,357
| Closed | -$2.67M | – | 748 |
|
|
2021
Q3 | $2.67M | Buy |
+234,357
| New | +$2.67M | 0.04% | 365 |
|